[1]
C. C. Chan and C. L. Prokopich, “Lifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease: Overview of Clinical Trial Program”, J Pharm Pharm Sci, vol. 22, no. 1, pp. 49–56, Jan. 2019.